{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T15:55:50Z","timestamp":1753890950965,"version":"3.41.2"},"reference-count":22,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,7,24]],"date-time":"2024-07-24T00:00:00Z","timestamp":1721779200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Fetal autoimmune atrioventricular block (AVB) is a rare but potentially life-threatening condition. It results from the passage of maternal anti-SSA\/Ro or Anti SSB\/La auto-antibodies into the fetal circulation, leading to inflammation and fibrosis of the AV node and often to irreversible damage. Besides AVB, these antibodies can also cause cardiomyopathies, but there is no evidence linking them to tachyarrhythmias. We present the case of a patient with significant risk factors for fetal AVB: a prior history of <jats:italic>hydrops fetalis<\/jats:italic>, high anti-SSA\/Ro antibody levels and hypothyroidism. In this case, the use of dexamethasone and intravenous immunoglobulin may have contributed to reversing the first-degree atrioventricular block detected at 19 weeks of gestation. Additionally, at 21 weeks, the fetus developed a tachyarrhythmia that needed treatment with flecainide. Soon after the birth, the newborn underwent ECG Holter and Wolff-Parkinson-White Syndrome (WPWS) was diagnosed. To our knowledge, the coexistence of fetal AVB and WPWS has never been described.<\/jats:p>","DOI":"10.3389\/fimmu.2024.1397103","type":"journal-article","created":{"date-parts":[[2024,7,24]],"date-time":"2024-07-24T04:42:00Z","timestamp":1721796120000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Dual challenge inside the womb: a case report of concomitant fetal atrio-ventricular block associated with maternal anti-SSA antibodies and fetal tachyarrhythmia diagnosed as Wolff-Parkinson-White syndrome after birth"],"prefix":"10.3389","volume":"15","author":[{"given":"Ana Teod\u00f3sio","family":"Ch\u00edcharo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M\u00f3nica","family":"Rebelo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana Rita","family":"Lopes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Jo\u00e3o","family":"Saavedra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Filipa","family":"Param\u00e9s","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana Rita","family":"Ara\u00fajo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana Rita","family":"Cruz-Machado","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lu\u00edsa","family":"Pinto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susana","family":"Capela","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2024,7,24]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1002\/art.24768","article-title":"Recurrence rates of cardiac manifestations associated with neonatal lupus and maternal\/fetal risk factors","volume":"60","author":"Llanos","year":"2009","journal-title":"Arthritis Rheum"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1093\/ehjci\/ehaa946.3203","article-title":"The prevalence of Wolff-Parkinson-White syndrome in newborns \u2013 results from a large general population study","volume":"41","author":"Paerregaard","year":"2020","journal-title":"Eur Heart J"},{"key":"B3","article-title":"Neonatal lupus erythematosus: clinical manifestations and management","author":"Chunharas","year":"2002","journal-title":"J Med Assoc Thai"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2021.759260","article-title":"Successful prevention of fetal autoimmune-mediated heart block by combined therapies with hydroxychloroquine and intravenous immunoglobulin: A case report","volume":"8","author":"Zhao","year":"2021","journal-title":"Front Cardiovasc Med"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1111\/j.1432-2277.2010.01088.x","article-title":"Effect of IVIG administration on complement activation and HLA antibody levels","volume":"23","author":"Machimoto","year":"2010","journal-title":"Transpl Int"},{"key":"B6","article-title":"Cardiac rhythm abnormalities during intravenous immunoglobulin G infusion for treatment of thrombocytopenia","volume":"19","author":"Savasan","year":"1997","journal-title":"J Pediatr Hemat"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.01299","article-title":"Adverse effects of immunoglobulin therapy","volume":"9","author":"Guo","year":"2018","journal-title":"Front Immunol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2017.09.005","article-title":"Should we treat congenital heart block with fluorinated corticosteroids","volume":"16","author":"Brucato","year":"2017","journal-title":"Autoimmun Rev"},{"key":"B9","article-title":"Neonatal lupus erythematosus","volume-title":"Dubois\u2019 lupus erythematosus and related syndromes","author":"Wahren-Herlenius","year":"2012"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2021.644122","article-title":"Prenatal management strategy for immune-associated congenital heart block in fetuses","volume":"8","author":"Liao","year":"2021","journal-title":"Front Cardiovasc Med"},{"key":"B11","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1161\/CIRCULATIONAHA.111.089268","article-title":"Maternal use of hydroxychloroquine is associated with a reduced risk of recurrent anti-SSA\/Roantibody\u2013 associated cardiac manifestations of neonatal lupus","volume":"126","author":"Izmirly","year":"2012","journal-title":"Circulation"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.3389\/fped.2020.607515","article-title":"Autoimmune congenital heart block: A review of biomarkers and management of pregnancy","volume":"8","author":"De Carolis","year":"2020","journal-title":"Front Pediatr"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kex191","article-title":"Prenatal exposure to antimalarials decreases the risk of cardiac but not non-cardiac neonatal lupus: a single-centre cohort study","volume":"56","author":"Barsalou","year":"2017","journal-title":"Rheumatology"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1515\/jpm-2020-0543","article-title":"Neonatal lupus erythematosus - practical guidelines","volume":"49","author":"Derdulska","year":"2021","journal-title":"J Perinat Med"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1002\/acr.24130","article-title":"2020 American college of rheumatology guideline for the management of reproductive health in rheumatic and musculoskeletal diseases","volume":"72","author":"Sammaritano","year":"2020","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.3325\/cmj.2013.54.564","article-title":"Maternal and fetal effects of antenatal exposure to corticosteroids","volume":"54","author":"Hui\u0107","year":"2013","journal-title":"Croatian Med J"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1002\/art.27350","article-title":"Failure of intravenous immunoglobulin to prevent congenital heart block: findings of a multicenter, prospective, observational study","volume":"62","author":"Pisoni","year":"2010","journal-title":"Arthritis Rheum"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1002\/art.27308","article-title":"Evaluation of fetuses in a study of intravenous immunoglobulin as preventive therapy for congenital heart block: results of a multicenter, prospective, open-label clinical trial","volume":"62","author":"Friedman","year":"2010","journal-title":"Arthritis Rheum"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000000086","article-title":"Intravenous immunoglobulin in the therapeutic armamentarium of systemic lupus erythematosus: a systematic review and meta-analysis","volume":"93","author":"Sakthiswary","year":"2014","journal-title":"Medicine"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.12932\/AP0671.34.2.2016","article-title":"A 10-year retrospective study of neonatal lupus erythematous in China","volume":"34","author":"Yu","year":"2016","journal-title":"Asian Pac J Allergy"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2008.12.027","article-title":"Prospective evaluation of fetuses with autoimmune-associated congenital heart block followed in the PR Interval and Dexamethasone Evaluation (PRIDE) Study","volume":"103","author":"Friedman","year":"2009","journal-title":"Am J Cardiol"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1002\/art.11498","article-title":"Intravenous immunoglobulin and placental transport of anti-Ro\/La antibodies: Comment on the letter by Kaaja and Julkunen","volume":"50","author":"Tran","year":"2004","journal-title":"Arthritis Rheum"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2024.1397103\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,24]],"date-time":"2024-07-24T04:42:05Z","timestamp":1721796125000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2024.1397103\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,24]]},"references-count":22,"alternative-id":["10.3389\/fimmu.2024.1397103"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2024.1397103","relation":{},"ISSN":["1664-3224"],"issn-type":[{"type":"electronic","value":"1664-3224"}],"subject":[],"published":{"date-parts":[[2024,7,24]]},"article-number":"1397103"}}